Drug industry in brisk investment for bio venture business.

Published: 2004-03-17 07:00:00

Updated: 2004-03-17 07:00:00

Many domestic drug manufacturers including LG Chemical, Cheiljedang, Dong-A, Daewoong, Hanmi and Bukwang showed an active investment move to a bio venture business for the enhancement of their competitiveness

The 2003 health industry white paper published by KHIDI indicated that 24 domestic ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK